Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Structure (London, England : 1993)|December 6, 2024
Does the structure of transthyretin amyloid fibrils vary depending on the organ of accumulation?Mineyuki MizuguchiYakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2013
[Structural study of polyglutamine tract-binding protein 1]Mineyuki Mizuguchi, Hitoshi OkazawaBiological & Pharmaceutical Bulletin|July 3, 2018
Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic CompoundsTakeshi Yokoyama, Mineyuki MizuguchiJournal of Medicinal Chemistry|September 11, 2020
Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current DevelopmentsTakeshi Yokoyama, Mineyuki MizuguchiJournal of Medicinal Chemistry|January 29, 2019
Crown Ethers as Transthyretin Amyloidogenesis InhibitorsTakeshi Yokoyama, Mineyuki MizuguchiJournal of Medicinal Chemistry|October 15, 2014
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretinTakeshi Yokoyama, Yuto Kosaka, Mineyuki MizuguchiProtein Expression and Purification|June 25, 2003
Expression of a synthetic gene encoding human transthyretin in Escherichia coliKimiaki Matsubara, Mineyuki Mizuguchi, Keiichi KawanoThe Biochemical Journal|September 13, 2022
The hydrophobic residue Leu73 is crucial for the high stability and low aggregation properties of murine transthyretinMei Nakagawa, Takayuki Obita, Mineyuki MizuguchiMethods in Molecular Biology (Clifton, N.J.)|June 29, 2019
Crystallization and Biophysical Approaches for Studying the Interactions Between the Vps4-MIT Domain and ESCRT-III ProteinsTakayuki Obita, Rieko Kojima, Mineyuki MizuguchiIucrj|February 1, 2021
Crystal structure of death-associated protein kinase 1 in complex with the dietary compound resveratrolTakeshi Yokoyama, Ryoya Suzuki, Mineyuki MizuguchiPageof 13